Barbara Ann Karmanos Cancer Institute-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Barbara Ann Karmanos Cancer Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011925
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Barbara Ann Karmanos Cancer Institute (Karmanos), a subsidiary of McLaren Health Care Corp is a healthcare institute that provides patient care and educational services. The institute offers patient care for the prevention, early detection, treatment and eventual eradication of cancer. Its cancer care programs comprise treatment options and side effects, clinical trials, radiology services, women’s wellness center, breast and cervical cancer control program, cord blood program, national asbestos-vermiculite center. The institute provides imaging services such as digital screening and diagnostic mammography; diagnostic ultrasound, PET, CT and MRI services; molecular breast imaging; general diagnostic radiology services; and cryoablation for benign fibroadenomas, among others. Karmanos is headquartered in Detroit, Michigan, the US.

Barbara Ann Karmanos Cancer Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
CureMeta Enters into Research Agreement with Barbara Ann Karmanos Cancer Institute 11
Asset Transactions 12
Residential Home Health Acquires Karmanos Hospice From Karmanos Cancer Institute 12
Acquisition 13
McLaren Health Care To Acquire Karmanos 13
Barbara Ann Karmanos Cancer Institute – Key Competitors 15
Barbara Ann Karmanos Cancer Institute – Key Employees 16
Barbara Ann Karmanos Cancer Institute – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Government and Public Interest 18
May 23, 2017: Karmanos Cancer Institute wins federal grant renewal for membership in prestigious Prostate Cancer Clinical Trials Consortium 18
Other Significant Developments 19
Jan 11, 2017: Karmanos Cancer Institute joins nation’s leading cancer centers to endorse HPV vaccine 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Key Facts 2
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Barbara Ann Karmanos Cancer Institute, Deals By Therapy Area, 2011 to YTD 2017 8
Barbara Ann Karmanos Cancer Institute, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
CureMeta Enters into Research Agreement with Barbara Ann Karmanos Cancer Institute 11
Residential Home Health Acquires Karmanos Hospice From Karmanos Cancer Institute 12
McLaren Health Care To Acquire Karmanos 13
Barbara Ann Karmanos Cancer Institute, Key Competitors 15
Barbara Ann Karmanos Cancer Institute, Key Employees 16
Barbara Ann Karmanos Cancer Institute, Other Locations 17

★海外企業調査レポート[Barbara Ann Karmanos Cancer Institute-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Valneva SE (VLA):製薬・医療:M&Aディール及び事業提携情報
    Summary Valneva SE (Valneva) is a biotech company that develops lifesaving vaccines. The company’s products include IXIARO, a vaccine indicated for the prevention of Japanese encephalitis; and Dukoral, a vaccine indicated for the prevention of cholera and diarrhea; clostridium difficile, lyme, chiku …
  • PT Charoen Pokphand Indonesia Tbk (CPIN):企業の財務・戦略的SWOT分析
    PT Charoen Pokphand Indonesia Tbk (CPIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Milagen Inc:企業の製品パイプライン分析
    Summary Milagen Inc (Milagen) is a medical device company. It provides diagnostic products. The company generates antibody reagents against the human proteome. It discovers, develops and markets non invasive immunodiagnostic products for monitoring, surveillance and detection of cancers. Milagen off …
  • Medicago Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a clinical-stage biotechnology company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. I …
  • A123 Systems LLC:企業の戦略的SWOT分析
    A123 Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Christian Dior SE:戦略・SWOT・企業財務分析
    Christian Dior SE - Strategy, SWOT and Corporate Finance Report Summary Christian Dior SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Rollprint Packaging Products Inc.:企業の戦略・SWOT・財務情報
    Rollprint Packaging Products Inc. - Strategy, SWOT and Corporate Finance Report Summary Rollprint Packaging Products Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Mannatech Inc (MTEX):企業の財務・戦略的SWOT分析
    Mannatech Inc (MTEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • FirstEnergy Corp (FE):電力:M&Aディール及び事業提携情報
    Summary FirstEnergy Corp. (FirstEnergy) is a diversified energy company, which generates, transmits, distributes and sells electricity. The company’s regulated distribution companies form one of the nation's largest investor-owned electric systems. Its major electricity generating assets include coa …
  • AbSci LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary AbSci LLC (AbSci) is a biotechnology company which develops protein production technologies. The company offers SoluPro, a genetically engineered semi-oxidizing cytoplasm and a dual inducible promoter system that enables scalable production of antibodies, antibody fragments, and other solubl …
  • Goodman Group:企業のM&A・事業提携・投資動向
    Goodman Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Goodman Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Globavir Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates …
  • Athenex Inc (ATNX):製薬・医療:M&Aディール及び事業提携情報
    Summary Athenex Inc (Athenex), formerly Kinex Pharmaceuticals LLC, is a biopharmaceutical company focused on the discovery, development and commercialization novel medicines and cell therapies for the treatment of cancers. The company’s orascovery products candidates include oral formulations of pac …
  • Nichias Corp (5393):企業の財務・戦略的SWOT分析
    Nichias Corp (5393) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Jacobs Engineering Group Inc (JEC):電力:M&Aディール及び事業提携情報
    Summary Jacobs Engineering Group Inc (Jacobs) is a professional services company. It offers a diverse range of technical, professional, and construction services. The company's service portfolio includes project; process, scientific and specialty consulting; engineering and construction; and operati …
  • Mr. Price Group Ltd.:企業の戦略・SWOT・財務分析
    Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mr. Price Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lloyd’s of London:企業の戦略・SWOT・財務情報
    Lloyd's of London - Strategy, SWOT and Corporate Finance Report Summary Lloyd's of London - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • P. H. Glatfelter Company (GLT):企業の財務・戦略的SWOT分析
    P. H. Glatfelter Company (GLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Lundin Petroleum AB (LUPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lundin Petroleum AB (Lundin Petroleum) is an independent oil and gas exploration and production company that acquires, explores, develops and produces oil and gas properties in Norway. The company identifies and matures exploration targets, drill exploration wells, appraise discoveries, and …
  • PricewaterhouseCoopers International Limited:企業の戦略・SWOT・財務情報
    PricewaterhouseCoopers International Limited - Strategy, SWOT and Corporate Finance Report Summary PricewaterhouseCoopers International Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆